0000899243-20-019413.txt : 20200716
0000899243-20-019413.hdr.sgml : 20200716
20200716185120
ACCESSION NUMBER: 0000899243-20-019413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200714
FILED AS OF DATE: 20200716
DATE AS OF CHANGE: 20200716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stueland Katherine
CENTRAL INDEX KEY: 0001689575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36847
FILM NUMBER: 201032389
MAIL ADDRESS:
STREET 1: 458 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invitae Corp
CENTRAL INDEX KEY: 0001501134
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 271701898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 374-7782
MAIL ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: InVitae Corp
DATE OF NAME CHANGE: 20121105
FORMER COMPANY:
FORMER CONFORMED NAME: Locus Development Inc
DATE OF NAME CHANGE: 20100910
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-14
0
0001501134
Invitae Corp
NVTA
0001689575
Stueland Katherine
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO
CA
94103
0
1
0
0
Chief Commercial Officer
Common Stock
2020-07-14
4
S
0
1000
32.50
D
262075
D
These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019.
Includes an aggregate of 213,640 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
/s/ Katherine Stueland
2020-07-16